Hymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice

M. B. Bilò, V. Pravettoni, D. Bignardi, P. Bonadonna, M. Mauro, E. Novembre, O. Quercia, M. Cilia, G. Cortellini, M. T. Costantino, L. Cremonte, F. Lodi Rizzini, L. Macchia, F. Marengo, F. Murzilli, V. Patella, F. Reccardini, L. Ricciardi, E. Ridolo, A. RomanoE. Savi, D. Schiavino, M. Severino, E. A. Pastorello

Research output: Contribution to journalReview article

Abstract

Hymenoptera venom allergy is an epidemiologically underestimated condition and a major cause of morbidity worldwide. Preventing future allergic reactions in patients who experience a systemic reaction is based on the correct management of the emergency followed by an accurate diagnosis, prescription of adrenaline autoinjectors, and, where indicated, specific venom immunotherapy. Some epidemiological studies highlight our poor knowledge of this disease and the frequent inadequacy of its management. Moreover, they emphasize the importance of such a life-saving treatment as specific immunotherapy. The availability of high-quality hymenoptera venom extracts for diagnostic and therapeutic use has dramatically improved the prognosis and quality of life of allergic patients. Subcutaneous venom immunotherapy is currently the most effective form of allergen-based immunotherapy, with a carry-over effect lasting up to several years after its interruption. This report on the management of hymenoptera venom-allergic children and adults was prepared by a panel of Italian experts. The main objective of this consensus document is to review the scientific evidence related to diagnosis, therapy, and management of patients allergic to hymenoptera venom. Thus, we can improve our knowledge of the disease and promote good clinical practices. The present document provides practical suggestions for correct diagnosis, prescription of emergency therapy and immunotherapy, and strategies for patient care.

Original languageEnglish
Pages (from-to)180-205
Number of pages26
JournalJournal of investigational allergology & clinical immunology
Volume29
Issue number3
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Hymenoptera
Venoms
Hypersensitivity
Immunotherapy
Prescriptions
Immunologic Desensitization
Emergency Treatment
Therapeutic Uses
Epinephrine
Epidemiologic Studies
Patient Care
Emergencies
Quality of Life
Morbidity
Therapeutics

Keywords

  • Adults
  • Children
  • Diagnosis
  • Efficacy
  • Hymenoptera
  • Immunotherapy
  • Management
  • Safety

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Hymenoptera Venom Allergy : Management of Children and Adults in Clinical Practice. / Bilò, M. B.; Pravettoni, V.; Bignardi, D.; Bonadonna, P.; Mauro, M.; Novembre, E.; Quercia, O.; Cilia, M.; Cortellini, G.; Costantino, M. T.; Cremonte, L.; Lodi Rizzini, F.; Macchia, L.; Marengo, F.; Murzilli, F.; Patella, V.; Reccardini, F.; Ricciardi, L.; Ridolo, E.; Romano, A.; Savi, E.; Schiavino, D.; Severino, M.; Pastorello, E. A.

In: Journal of investigational allergology & clinical immunology, Vol. 29, No. 3, 01.01.2019, p. 180-205.

Research output: Contribution to journalReview article

Bilò, MB, Pravettoni, V, Bignardi, D, Bonadonna, P, Mauro, M, Novembre, E, Quercia, O, Cilia, M, Cortellini, G, Costantino, MT, Cremonte, L, Lodi Rizzini, F, Macchia, L, Marengo, F, Murzilli, F, Patella, V, Reccardini, F, Ricciardi, L, Ridolo, E, Romano, A, Savi, E, Schiavino, D, Severino, M & Pastorello, EA 2019, 'Hymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice', Journal of investigational allergology & clinical immunology, vol. 29, no. 3, pp. 180-205. https://doi.org/10.18176/jiaci.0310
Bilò, M. B. ; Pravettoni, V. ; Bignardi, D. ; Bonadonna, P. ; Mauro, M. ; Novembre, E. ; Quercia, O. ; Cilia, M. ; Cortellini, G. ; Costantino, M. T. ; Cremonte, L. ; Lodi Rizzini, F. ; Macchia, L. ; Marengo, F. ; Murzilli, F. ; Patella, V. ; Reccardini, F. ; Ricciardi, L. ; Ridolo, E. ; Romano, A. ; Savi, E. ; Schiavino, D. ; Severino, M. ; Pastorello, E. A. / Hymenoptera Venom Allergy : Management of Children and Adults in Clinical Practice. In: Journal of investigational allergology & clinical immunology. 2019 ; Vol. 29, No. 3. pp. 180-205.
@article{6292bafcf1f54debb26795cd6e3d7e2a,
title = "Hymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice",
abstract = "Hymenoptera venom allergy is an epidemiologically underestimated condition and a major cause of morbidity worldwide. Preventing future allergic reactions in patients who experience a systemic reaction is based on the correct management of the emergency followed by an accurate diagnosis, prescription of adrenaline autoinjectors, and, where indicated, specific venom immunotherapy. Some epidemiological studies highlight our poor knowledge of this disease and the frequent inadequacy of its management. Moreover, they emphasize the importance of such a life-saving treatment as specific immunotherapy. The availability of high-quality hymenoptera venom extracts for diagnostic and therapeutic use has dramatically improved the prognosis and quality of life of allergic patients. Subcutaneous venom immunotherapy is currently the most effective form of allergen-based immunotherapy, with a carry-over effect lasting up to several years after its interruption. This report on the management of hymenoptera venom-allergic children and adults was prepared by a panel of Italian experts. The main objective of this consensus document is to review the scientific evidence related to diagnosis, therapy, and management of patients allergic to hymenoptera venom. Thus, we can improve our knowledge of the disease and promote good clinical practices. The present document provides practical suggestions for correct diagnosis, prescription of emergency therapy and immunotherapy, and strategies for patient care.",
keywords = "Adults, Children, Diagnosis, Efficacy, Hymenoptera, Immunotherapy, Management, Safety",
author = "Bil{\`o}, {M. B.} and V. Pravettoni and D. Bignardi and P. Bonadonna and M. Mauro and E. Novembre and O. Quercia and M. Cilia and G. Cortellini and Costantino, {M. T.} and L. Cremonte and {Lodi Rizzini}, F. and L. Macchia and F. Marengo and F. Murzilli and V. Patella and F. Reccardini and L. Ricciardi and E. Ridolo and A. Romano and E. Savi and D. Schiavino and M. Severino and Pastorello, {E. A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.18176/jiaci.0310",
language = "English",
volume = "29",
pages = "180--205",
journal = "Journal of Investigational Allergology and Clinical Immunology",
issn = "1018-9068",
publisher = "Esmon",
number = "3",

}

TY - JOUR

T1 - Hymenoptera Venom Allergy

T2 - Management of Children and Adults in Clinical Practice

AU - Bilò, M. B.

AU - Pravettoni, V.

AU - Bignardi, D.

AU - Bonadonna, P.

AU - Mauro, M.

AU - Novembre, E.

AU - Quercia, O.

AU - Cilia, M.

AU - Cortellini, G.

AU - Costantino, M. T.

AU - Cremonte, L.

AU - Lodi Rizzini, F.

AU - Macchia, L.

AU - Marengo, F.

AU - Murzilli, F.

AU - Patella, V.

AU - Reccardini, F.

AU - Ricciardi, L.

AU - Ridolo, E.

AU - Romano, A.

AU - Savi, E.

AU - Schiavino, D.

AU - Severino, M.

AU - Pastorello, E. A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Hymenoptera venom allergy is an epidemiologically underestimated condition and a major cause of morbidity worldwide. Preventing future allergic reactions in patients who experience a systemic reaction is based on the correct management of the emergency followed by an accurate diagnosis, prescription of adrenaline autoinjectors, and, where indicated, specific venom immunotherapy. Some epidemiological studies highlight our poor knowledge of this disease and the frequent inadequacy of its management. Moreover, they emphasize the importance of such a life-saving treatment as specific immunotherapy. The availability of high-quality hymenoptera venom extracts for diagnostic and therapeutic use has dramatically improved the prognosis and quality of life of allergic patients. Subcutaneous venom immunotherapy is currently the most effective form of allergen-based immunotherapy, with a carry-over effect lasting up to several years after its interruption. This report on the management of hymenoptera venom-allergic children and adults was prepared by a panel of Italian experts. The main objective of this consensus document is to review the scientific evidence related to diagnosis, therapy, and management of patients allergic to hymenoptera venom. Thus, we can improve our knowledge of the disease and promote good clinical practices. The present document provides practical suggestions for correct diagnosis, prescription of emergency therapy and immunotherapy, and strategies for patient care.

AB - Hymenoptera venom allergy is an epidemiologically underestimated condition and a major cause of morbidity worldwide. Preventing future allergic reactions in patients who experience a systemic reaction is based on the correct management of the emergency followed by an accurate diagnosis, prescription of adrenaline autoinjectors, and, where indicated, specific venom immunotherapy. Some epidemiological studies highlight our poor knowledge of this disease and the frequent inadequacy of its management. Moreover, they emphasize the importance of such a life-saving treatment as specific immunotherapy. The availability of high-quality hymenoptera venom extracts for diagnostic and therapeutic use has dramatically improved the prognosis and quality of life of allergic patients. Subcutaneous venom immunotherapy is currently the most effective form of allergen-based immunotherapy, with a carry-over effect lasting up to several years after its interruption. This report on the management of hymenoptera venom-allergic children and adults was prepared by a panel of Italian experts. The main objective of this consensus document is to review the scientific evidence related to diagnosis, therapy, and management of patients allergic to hymenoptera venom. Thus, we can improve our knowledge of the disease and promote good clinical practices. The present document provides practical suggestions for correct diagnosis, prescription of emergency therapy and immunotherapy, and strategies for patient care.

KW - Adults

KW - Children

KW - Diagnosis

KW - Efficacy

KW - Hymenoptera

KW - Immunotherapy

KW - Management

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=85068476337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068476337&partnerID=8YFLogxK

U2 - 10.18176/jiaci.0310

DO - 10.18176/jiaci.0310

M3 - Review article

C2 - 30183660

AN - SCOPUS:85068476337

VL - 29

SP - 180

EP - 205

JO - Journal of Investigational Allergology and Clinical Immunology

JF - Journal of Investigational Allergology and Clinical Immunology

SN - 1018-9068

IS - 3

ER -